Target intelligence / Profile preview

RAB30 divergent transcript (RAB30-DT)

Target
RAB30-DT
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA, Divergent transcript
01

Overview

RAB30 divergent transcript (RAB30-DT, also known as RAB30-AS1) is a long non-coding RNA gene located at chromosome 11q14.1[5][8]. It is classified as a divergent transcript and antisense RNA, transcribed from the opposite strand relative to the protein-coding RAB30 gene. Its molecular and biological functions are currently uncharacterized, with no known protein product and no direct evidence linking it to specific diseases or a therapeutic mechanism[1][3][5]. There are some associations with genetic variants in this region in large genetic studies, but RAB30-DT itself is not considered a therapeutic or biomarker target, and no interacting drugs or safety concerns have been reported[5][7]. In summary, RAB30-DT is a non-coding RNA gene with poorly characterized function and no current role as a drug target or disease biomarker.

Other names
RAB30-AS1RAB30 antisense RNA 1 (head to head)RAB30 divergent transcript
02

Mechanism of action

None established, as it is not a validated drug target.

03

Biological functions

Unknown/Not well characterized. No specific functions are assigned in current reference databases
04

Disease associations

Not clearly established. There are genome-wide association studies (GWAS) linking the locus to certain traits, but no definitive causative disease role has been established

Beyond the preview

Go deeper on RAB30 divergent transcript (RAB30-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RAB30 divergent transcript (RAB30-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call